Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Plasma Post-operative miR-21 Expression in the Prognosis of Gastric Cancers

  • Ma, Guo-Jian (Department of Genetics and Molecular Biology, Jiangsu Cancer Hospital) ;
  • Gu, Rong-Min (Department of General Surgery, Jiangsu Cancer Hospital) ;
  • Zhu, Ming (Department of Genetics and Molecular Biology, Jiangsu Cancer Hospital) ;
  • Wen, Xu (Department of General Surgery, Jiangsu Cancer Hospital) ;
  • Li, Jin-Tian (Department of Genetics and Molecular Biology, Jiangsu Cancer Hospital) ;
  • Zhang, Yuan-Ying (Department of Genetics and Molecular Biology, Jiangsu Cancer Hospital) ;
  • Zhang, Xiao-Mei (Department of Genetics and Molecular Biology, Jiangsu Cancer Hospital) ;
  • Chen, Sen-Qing (Department of Genetics and Molecular Biology, Jiangsu Cancer Hospital)
  • Published : 2013.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Tumor-associated microRNAs have been detected in serum or plasma, but whether plasma microRNA-21 (miR-21) could be a potential circulating biomarker for gastric cancer (GC) prognosis in Chinese is still uncertain. Real-time quantitative reverse transcription PCR (qRT-PCR) was employed in this study to compare the relative expression of miR-21 between pre-operative and post-operative paired plasmas from 42 patients with primary GCs. The results showed that the expression levels of miR-21 in the post-operative plasmas were significantly reduced by an average of 18.2 times in all patients when compared to the pre-operative plasmas, and by 22.1 times in the subgroup of patients without family history, while only 1.76 times in the subgroup of patients with a family history. With respect of clinicopathological characteristics, the plasma miR-21 expression was highly associated with differentiation degree and lymph node metastasis rate. The results suggested plasma miR-21 could be a novel potential biomarker for GC prognosis and evaluation of surgery outcomes, especially in patients without a family history.

Keywords

References

  1. Arroyo JD, Chevillet JR, Kroh EM, et al (2011). Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA, 108, 5003-8. https://doi.org/10.1073/pnas.1019055108
  2. Chan M, Liaw CS, Ji SM, et al (2013). Identification of circulating microRNA signatures for breast cancer detection. Clin Cancer Res, 19, 4477-87. https://doi.org/10.1158/1078-0432.CCR-12-3401
  3. Chan S, Wu C, Li A, Chi C, et al (2008). miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res, 28, 907-11.
  4. Chen X, Ba Y, Ma L, et al (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 18, 997-1006. https://doi.org/10.1038/cr.2008.282
  5. Cocucci E, Racchetti G, Meldolesi J (2009). Shedding microvesicles: artefacts no more. Trends Cell Biol, 19, 43-51. https://doi.org/10.1016/j.tcb.2008.11.003
  6. Deddens JC, Colijn JM, Oerlemans MI, et al (2013). Circulating microRNAs as novel biomarkers for the early diagnosis of acute coronary syndrome. J Cardiovasc Transl Res, 6, 884-98. https://doi.org/10.1007/s12265-013-9493-9
  7. Gong EJ, Ahn JY, Jung HY, et al (2013). Risk factors and clinical outcomes of gastric cancer identified by screening endoscopy: a case-control study. J Gastroenterol Hepatol, Oct. 3. doi:10.1111/jgh.12387 [Epub ahead of print].
  8. He L, Thomson JM, Hemann MT, et al (2005). A microRNA polycistron as a potential human oncogene. Nature, 435, 828-33. https://doi.org/10.1038/nature03552
  9. Hiyoshi Y, Kamohara H, Karashima R, et al (2009). MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res, 15, 1915-22. https://doi.org/10.1158/1078-0432.CCR-08-2545
  10. Huang Z, Huang D, Ni S, et al (2010). Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer, 127, 118-26. https://doi.org/10.1002/ijc.25007
  11. Li B, Zhao Y, Guo G, et al (2012). Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One, 7, e41629. https://doi.org/10.1371/journal.pone.0041629
  12. Li C, Li J, Cai Q, et al (2013). MiRNA-199a-3p: a potential circulating diagnostic biomarker for early gastric cancer. J Surg Oncol, 108, 89-92. https://doi.org/10.1002/jso.23358
  13. Liu J, Lei DP, Jin T, et al (2011). Altered expression of miR-21 and PTEN in human laryngeal and hypopharyngeal squamous cell carcinomas. Asian Pac J Cancer Prev, 12, 2653-7.
  14. Ma WJ, Lv GD, Tuersun A, et al (2011). Role of microRNA-21 and effect on PTEN in Kazakh's esophageal squamous cell carcinoma. Mol Biol Rep, 38, 3253-60. https://doi.org/10.1007/s11033-010-0480-9
  15. Marcon F, Silvestrini F, Siniscalchi E, et al (2011). Gene expression in response to ionizing radiation and family history of gastric cancer. Fam Cancer, 10, 107-18. https://doi.org/10.1007/s10689-010-9396-8
  16. Mitchell P S, Parkin R K, Kroh E M, et al (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Nat Acad Sci USA, 105, 10513-8. https://doi.org/10.1073/pnas.0804549105
  17. Motoyama K, Inoue H, Mimori K, et al (2010). Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer. Int J Oncol, 36, 1089-95.
  18. Ng EK, Chong WW, Jin H, et al (2009). Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut, 58, 1375-81. https://doi.org/10.1136/gut.2008.167817
  19. Pan X, Wang ZX, Wang R (2010). MicroRNA-21: a novel therapeutic target in human cancer. Cancer Biol Ther, 10, 1224-32. https://doi.org/10.4161/cbt.10.12.14252
  20. Tambyah PA, Sepramaniam S, Mohamed Ali J, et al (2013). MicroRNAs in circulation are altered in response to influenza a virus infection in humans. PLoS One, 8, e76811. https://doi.org/10.1371/journal.pone.0076811
  21. Thery C, Zitvogel L, Amigorena S (2002). Exosomes: composition, biogenesis and function. Nat Rev Immunol, 2, 569-79. https://doi.org/10.1038/nri855
  22. Tracz AF, Peczek L, Zuk K, et al (2013). Effect of Helicobacter pylori eradication on the expression level of SATB1 and c-Myc genes in gastric mucosa of patients with family history of gastric cancer. Pol Merkur Lekarski, 34, 269-76.
  23. Wang B, Zhang Q (2012). The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. J Cancer Res Clin Oncol, 138, 1659-66. https://doi.org/10.1007/s00432-012-1244-9
  24. Wong TS, Liu XB, Wong BY, et al (2008). Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res, 14, 2588-92. https://doi.org/10.1158/1078-0432.CCR-07-0666
  25. Zeng Z, Wang J, Zhao L, et al (2013). Potential role of microRNA-21 in the diagnosis of gastric cancer: a Metaanalysis. PLos One, 8, e73278. https://doi.org/10.1371/journal.pone.0073278
  26. Zhang BG, Li JF, Yu BQ, et al (2012). microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep, 27, 1019-26. https://doi.org/10.3892/or.2012.1645
  27. Zhang JG, Wang JJ, Zhao F, et al (2010). MicroRNA-21 (miR-21). represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta, 411, 846-52. https://doi.org/10.1016/j.cca.2010.02.074
  28. Zhang Z, Li Z, Gao C, et al (2008). miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest, 88, 1358-66. https://doi.org/10.1038/labinvest.2008.94
  29. Zuk K, Peczek L, Stec-Michalska K, et al (2012). Family history of gastric cancer correlates with decreased expression of HINT1 tumor suppressor gene in gastric mucosa of dyspeptic patients. Oncol Lett, 3, 219-23. https://doi.org/10.3892/ol.2011.456

Cited by

  1. Pemetrexed is Mildly Active with Good Tolerability in Treating Patients with Gastric Cancer vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7137
  2. Association of miR-193b Down-regulation and miR-196a up-Regulation with Clinicopathological Features and Prognosis in Gastric Cancer vol.15, pp.20, 2014, https://doi.org/10.7314/APJCP.2014.15.20.8893
  3. Increased Expression of P2RY2, CD248 and EphB1 in Gastric Cancers from Chilean Patients vol.15, pp.5, 2014, https://doi.org/10.7314/APJCP.2014.15.5.1931
  4. Celastrol induces cell cycle arrest by MicroRNA-21-mTOR-mediated inhibition p27 protein degradation in gastric cancer vol.15, pp.1, 2015, https://doi.org/10.1186/s12935-015-0256-3
  5. MicroRNAs May Serve as Emerging Molecular Biomarkers for Diagnosis and Prognostic Assessment or as Targets for Therapy in Gastric Cancer vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.4813
  6. Clinical Significance of Upregulation of mir-196a-5p in Gastric Cancer and Enriched KEGG Pathway Analysis of Target Genes vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.1781
  7. Differential MIR-21 Expression in Plasma From Mesenteric Versus Peripheral Veins vol.94, pp.1, 2015, https://doi.org/10.1097/MD.0000000000000145
  8. Gastric biomarkers: a global review vol.14, pp.1, 2016, https://doi.org/10.1186/s12957-016-0969-3
  9. Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns vol.96, pp.6, 2016, https://doi.org/10.1038/labinvest.2016.33
  10. Characterization of exosomal RNAs derived from human gastric cancer cells by deep sequencing vol.39, pp.4, 2017, https://doi.org/10.1177/1010428317695012
  11. MicroRNAs in Brain Metastases: Potential Role as Diagnostics and Therapeutics vol.15, pp.6, 2014, https://doi.org/10.3390/ijms150610508
  12. Circulating MicroRNAs as Biomarkers and Mediators of Cell–Cell Communication in Cancer vol.3, pp.4, 2015, https://doi.org/10.3390/biomedicines3040270
  13. New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies vol.17, pp.5, 2016, https://doi.org/10.3390/ijms17050627
  14. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer vol.17, pp.6, 2016, https://doi.org/10.3390/ijms17060945
  15. Circulating microRNAs as diagnostic and therapeutic biomarkers in gastric and esophageal cancers vol.233, pp.11, 2018, https://doi.org/10.1002/jcp.26850
  16. Extracellular Vesicles As miRNA Nano-Shuttles: Dual Role in Tumor Progression vol.13, pp.2, 2018, https://doi.org/10.1007/s11523-018-0551-8